It’s been just revealed that the first COVID-19 vaccine that’s been tested in the US managed to revamp people’s immune system just the way that experts had hoped. Experts reported the other day that the shots are poised to begin the key final testing.
“No matter how you slice this, this is good news,” Dr. Anthony Fauci, the U.S. government’s top infectious disease expert, told The Associated Press.
It’s been revealed that the experimental vaccine, developed by Fauci’s colleagues at the National Institutes of Health and Moderna Inc., will start the most important step around July 27: “A 30,000-person study to prove if the shots really are strong enough to protect against the coronavirus,” according to the reports.
It’s been also revealed that the early volunteers had developed what are called neutralizing antibodies in their bloodstream.
These are some molecules key to blocking infection and they were at levels comparable to the ones found in people who survived COVID-19. The team of experts reported this in the New England Journal of Medicine.
“This is an essential building block that is needed to move forward with the trials that could actually determine whether the vaccine does protect against infection,” according to Dr. Lisa Jackson of the Kaiser Permanente Washington Research Institute in Seattle, who led the study.
We don’t have any guarantees yet, but the government is hoping to have some great results by the end of 2020 – this would mean a record-setting speed fo developing a vaccine.
Coronavirus in the news
We are all waiting for a viable coronavirus vaccine and useful treatments and experts from around the globe are working together to fight this new coronavirus pandemic that changed our lives.
Microsoft founder, Bill Gates is warning people that Covid-19 medications, treatments and future vaccines should be distributed to the people who need them most and not to the highest bidder.
On the other hand, the danger of coronavirus could pass soon, according to the latest reports.